INSIGHTS ON QUALITY ASSURANCE
-
503A Vs. 503B: Turning Regulatory Complexity Into Practical Compliance
Navigating human drug compounding requires aligning Section 503A and Section 503B operations with cGMP expectations, robust quality management systems, and standing inspection readiness.
-
MG America Virtual Pharma Expo September 2025: Oral Solid Dose Manufacturing And Packaging
Learn how to select the right containment solutions, explore technologies for encapsulated manufacturing, and identify critical phases in containment projects to protect operators and the environment.
-
Exploring Agentic AI In GMP Operations
Discover how agentic AI is poised to transform Enterprise Asset Management in regulated industries to enhance compliance, reduce downtime, and bridge fragmented systems for resilient operations.
-
Driving Operator Safety And Process Efficiency
Discover how ergonomic design and workflow simplification can turn routine production tasks into strategic advantages, as well as practical ways to boost safety, efficiency, and innovation.
-
A Holistic Approach To CCI Is A Deterministic Approach1/30/2026
A modern approach to CCI blends smart design, risk‑based strategies, and deterministic testing to safeguard sterile products. Learn how lifecycle thinking and practical sampling plans strengthen quality.
-
Your Global Partner In Pharmaceutical Contamination Control6/24/2025
Ensure cleanroom compliance with an expert team that helps you interpret critical data, align with global regulations, and maintain control through proactive contamination strategies.
-
A CCS Is A Purpose-Built Machine, Not A Black Box: Understand The Workings9/2/2026
Learn how to transform your contamination control strategy into a dynamic operational framework that identifies risks and strengthens facility control.
-
The Role Of CAPA In Pharma10/17/2024
Establishing a robust, risk-based CAPA system prevents recurring process deviations, satisfies ICH Q10 guidelines, and ensures standing inspection readiness.
-
How Does SUS Integrity Change Across The Drug Product Lifecycle?9/24/2026
Learn how phase-appropriate risk justification, validation, documentation, and lifecycle controls can strengthen sterility assurance while reducing the potential for rework and delays.
QUALITY ASSURANCE SOLUTIONS
-
Match each CMC question to the right risk framework. See which tools help identify risk, reveal its drivers, and prioritize action across development and lifecycle risk management.
-
Observe the viability of your cells with the field-upgradeable cellular imaging option for the SpectraMax i3/i3x Multi-mode Detection Platform.
-
Explore how specialized analytical expertise and advanced instrumentation enable precise nitrosamine testing to help drug developers meet strict and evolving regulatory requirements.
-
Understand how to confidently meet GxP compliance in the life sciences. Explore a framework encompassing people, processes, products, and services for regulatory adherence and data integrity.
-
Suture production must account for wide variations in thread materials, needle dimensions, and tray designs. Learn how these factors influence automated handling, assembly, and process design across a range of manufacturing requirements.